Market Closed -
Nasdaq
04:00:00 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
2.2
USD
|
0.00%
|
|
-3.93%
|
-17.91%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,324
|
145
|
511.2
|
423.2
|
-
|
-
|
Enterprise Value (EV)
1 |
2,649
|
1,416
|
511.2
|
1,734
|
1,730
|
1,723
|
P/E ratio
|
-10.4
x
|
-0.22
x
|
-3.77
x
|
-19.5
x
|
-653
x
|
44.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.79
x
|
0.08
x
|
0.27
x
|
0.21
x
|
0.2
x
|
0.19
x
|
EV / Revenue
|
1.58
x
|
0.79
x
|
0.27
x
|
0.88
x
|
0.83
x
|
0.79
x
|
EV / EBITDA
|
14.4
x
|
11
x
|
3.67
x
|
11.7
x
|
10.7
x
|
9.85
x
|
EV / FCF
|
-97
x
|
-23.4
x
|
-
|
160
x
|
150
x
|
78.3
x
|
FCF Yield
|
-1.03%
|
-4.27%
|
-
|
0.63%
|
0.67%
|
1.28%
|
Price to Book
|
2.08
x
|
-35.3
x
|
-
|
-3.08
x
|
-3.23
x
|
-3.72
x
|
Nbr of stocks (in thousands)
|
184,164
|
185,918
|
190,733
|
192,379
|
-
|
-
|
Reference price
2 |
7.190
|
0.7800
|
2.680
|
2.200
|
2.200
|
2.200
|
Announcement Date
|
3/28/22
|
3/16/23
|
3/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,495
|
1,679
|
1,788
|
1,895
|
1,975
|
2,075
|
2,179
|
EBITDA
1 |
-
|
184.2
|
129.3
|
139.2
|
148.4
|
161.1
|
175
|
EBIT
1 |
-
|
163.7
|
108
|
125.4
|
135.4
|
147.6
|
161.3
|
Operating Margin
|
-
|
9.75%
|
6.04%
|
6.62%
|
6.86%
|
7.11%
|
7.4%
|
Earnings before Tax (EBT)
1 |
-
|
-113.6
|
-663.8
|
-139
|
-21.9
|
-5.6
|
2
|
Net income
1 |
-
|
-117
|
-662
|
-134.5
|
-21.97
|
-3.969
|
9.943
|
Net margin
|
-
|
-6.97%
|
-37.03%
|
-7.1%
|
-1.11%
|
-0.19%
|
0.46%
|
EPS
2 |
-8.300
|
-0.6900
|
-3.570
|
-0.7100
|
-0.1129
|
-0.003370
|
0.0494
|
Free Cash Flow
1 |
-
|
-27.3
|
-60.42
|
-
|
10.87
|
11.54
|
22
|
FCF margin
|
-
|
-1.63%
|
-3.38%
|
-
|
0.55%
|
0.56%
|
1.01%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
7.32%
|
7.16%
|
12.57%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
221.27%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/1/21
|
3/28/22
|
3/16/23
|
3/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
411.3
|
414.1
|
450.5
|
443
|
443
|
451.1
|
466.4
|
471.9
|
478
|
478.8
|
483.9
|
490.8
|
498.5
|
501.4
|
511.2
|
EBITDA
1 |
45.81
|
45.84
|
37.95
|
36.97
|
24.75
|
29.66
|
28.48
|
35.86
|
36.19
|
38.66
|
29.85
|
35.75
|
40.21
|
42.52
|
33.08
|
EBIT
1 |
40.66
|
40.46
|
32.13
|
30.93
|
19.83
|
25.12
|
24.44
|
32.36
|
33.23
|
35.38
|
26.49
|
32.72
|
37.1
|
39.29
|
30.06
|
Operating Margin
|
9.89%
|
9.77%
|
7.13%
|
6.98%
|
4.48%
|
5.57%
|
5.24%
|
6.86%
|
6.95%
|
7.39%
|
5.47%
|
6.67%
|
7.44%
|
7.84%
|
5.88%
|
Earnings before Tax (EBT)
1 |
0.99
|
-122.1
|
27.93
|
-474.2
|
21.63
|
-239.1
|
-30.43
|
24.79
|
-101.8
|
-31.6
|
-12.75
|
-7.4
|
-2.2
|
0.9
|
-8.7
|
Net income
1 |
2.09
|
-126.2
|
25.33
|
-473.9
|
24.3
|
-237.8
|
-32
|
25.6
|
-102.4
|
-25.74
|
-11.39
|
-6.855
|
-2.971
|
-0.4766
|
-7.4
|
Net margin
|
0.51%
|
-30.48%
|
5.62%
|
-106.98%
|
5.48%
|
-52.71%
|
-6.86%
|
5.42%
|
-21.42%
|
-5.37%
|
-2.35%
|
-1.4%
|
-0.6%
|
-0.1%
|
-1.45%
|
EPS
2 |
0.0100
|
-0.6800
|
0.1400
|
-2.560
|
0.1300
|
-1.280
|
-0.1700
|
0.1300
|
-0.5400
|
-0.1300
|
-0.0630
|
-0.0365
|
-0.0135
|
-0.000100
|
-0.0400
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/15/21
|
3/28/22
|
5/11/22
|
8/10/22
|
11/9/22
|
3/16/23
|
5/11/23
|
8/10/23
|
11/9/23
|
3/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
1,325
|
1,271
|
-
|
1,310
|
1,307
|
1,300
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
7.19
x
|
9.829
x
|
-
|
8.83
x
|
8.112
x
|
7.429
x
|
Free Cash Flow
1 |
-
|
-27.3
|
-60.4
|
-
|
10.9
|
11.5
|
22
|
ROE (net income / shareholders' equity)
|
-
|
15.7%
|
0.23%
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
3.41%
|
0.04%
|
-
|
-1.13%
|
-0.49%
|
0.3%
|
Assets
1 |
-
|
-3,432
|
-1,844,620
|
-
|
1,952
|
812.9
|
3,363
|
Book Value Per Share
2 |
-
|
3.450
|
-0.0200
|
-
|
-0.7100
|
-0.6800
|
-0.5900
|
Cash Flow per Share
2 |
-
|
-0.0700
|
-0.2600
|
0.1200
|
0.1200
|
0.1500
|
0.2200
|
Capex
1 |
-
|
16
|
12
|
-
|
7.58
|
10
|
10.4
|
Capex / Sales
|
-
|
0.95%
|
0.67%
|
-
|
0.38%
|
0.48%
|
0.48%
|
Announcement Date
|
4/1/21
|
3/28/22
|
3/16/23
|
3/14/24
|
-
|
-
|
-
|
Average target price
2.57
USD Spread / Average Target +16.82% Consensus |
1st Jan change
|
Capi.
|
---|
| -17.91% | 423M | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -3.97% | 11.66B | | -1.42% | 11.72B | | -31.75% | 11.77B |
Other Healthcare Facilities & Services
|